Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mahalingam S. Sundaram
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer in Vitro and Inflammatory Bowel Disease in Vivo
PLoS ONE
Multidisciplinary
A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines That Targets Snake Venom Phospholipase A2
PLoS ONE
Multidisciplinary
Related publications
NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases
Advances in Protein Chemistry and Structural Biology
Biochemistry
Structural Biology
Novel Therapeutic Targets in Inflammatory Bowel Disease
Prescriber
Pharmacology
Cancer and Reconstructive Surgery in Inflammatory Bowel Disease
Linköping University Medical Dissertations
Immunotherapy in Inflammatory Bowel Disease: Novel and Emerging Treatments
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Differential Activation of NF-κB and Nitric Oxide in Lymphocytes Regulates in Vitro and in Vivo Radiosensitivity
Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Mutagenesis
Toxicology
Health
Genetics
Variable NF-κB Pathway Responses in Colon Cancer Cells Treated With Chemotherapeutic Drugs
BMC Cancer
Cancer Research
Oncology
Genetics
Induction of cIAP-2 in Human Colon Cancer Cells Through PKCδ/NF-κB
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment in Vitro and in Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis
PLoS ONE
Multidisciplinary
Correction: Antibiotics and Probiotics in Inflammatory Bowel Disease: When to Use Them?
Frontline Gastroenterology
Hepatology
Gastroenterology